The United States is expected to dominate the North American autotransfusion systems market, throughout the forecast period. The presence of major autotransfusion system companies, the high volume of surgeries performed in the country, and the well-established healthcare infrastructure are some of the aspects driving the demand for autotransfusion products.
Rockville, Maryland, United States, 2nd Feb 2023 – According to a recent report by Fact.MR, The global autotransfusion systems market is valued at US$ 315.4 million in 2023 and is predicted to expand at a CAGR of 4% from 2023 to 2033, as per this latest industry analysis by Fact.MR, a market research and competitive intelligence provider.
Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8327
Medical equipment known as an autotransfusion system gathers and processes the patient’s blood during a specific surgical procedure, eliminating the need for any blood transfusions from outside donors. The innovative operational architecture of this device enables it to give essential autologous blood during various device applications.
Some of the major drivers anticipated to propel sales growth during the projected period include the increasing rate of surgical operations such as liver or other organ transplant surgeries. Also, the rapidly rising rate of the senior population, growing cases related to blood disorders, and technological developments are boosting the demand for autotransfusion systems.
Key Takeaways from Market Study
- The global autotransfusion systems market is expected to reach US$ 466.8 million by 2033.
- The market in China is predicted to expand at a high CAGR of 4% during the projected period.
- Demand for autotransfusion products is expected to rise at a CAGR of 4.5% during the next 10 years.
- Sales of autotransfusion accessories are anticipated to evolve at a 3% CAGR during the forecast period.
Globally, cardiovascular illnesses are a leading cause of death. Numerous coronary artery disorders (CAD) are thought to be caused by the build-up of cholesterol and other substances in the coronary arteries.
- The prevalence of heart failure is 5.8 million in the United States and over 23 million worldwide, according to the National Center for Biotechnology Information (NCBI).
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=8327
Thus, the rising rate of surgeries related to the heart is driving the sales of autotransfusion systems. Along with the presence of developed healthcare infrastructure, the rising usage of autologous blood transfusion in major orthopedic and cardiovascular procedures is predicted to fuel market growth in the North America region over the forecast period.
Europe is likely to present sizable growth opportunities for market players due to the rapidly rising rate of accidents and trauma in countries such as the United Kingdom, France, and Germany, as well as a significant emphasis on adopting intraoperative and postoperative cell salvage procedures.
Recent Market Developments
- Fresenius SE & Co. KGaA established a partnership with Omnicell, Inc. in November 2021 to provide cutting-edge new pharmacy technology to United States hospitals and health systems.
- In June 2020, ProCell Surgical Inc. introduced ProCell, its first medical gadget created to efficiently automate the labour-intensive and antiquated process of surgical sponge-blood recovery for intraoperative autotransfusion.
Key Companies Profiled
- Atrium Medical Corporation (A Part of Getinge Group)
- Becton, Dickinson and Company
- Beijing ZKSK Technology Co., Ltd.
- Braile Biomédica
- Fresenius Medical Care AG & Co. KGaA
- Gen World Medical Devices
- Haemonetics Corporation
- Livanova PLC
- Medtronic PLC
Get Full Access of Complete Report: https://www.factmr.com/checkout/8327
Key Segments of Autotransfusion Systems Industry Research
- By Type :
- Autotransfusion Products
- Autotransfusion Accessories
- By Application :
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Obstetrics & Gynecological Surgeries
- Neurological Surgeries
- By End User :
- Ambulatory Surgical Centers
- Specialty Clinics
- By Region :
- North America
- Latin America
- East Asia
- South Asia & Oceania
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global autotransfusion systems market, presenting historical demand data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.
The study divulges essential insights on the market on the basis of type (autotransfusion products, autotransfusion accessories), application (cardiovascular surgeries, orthopedic surgeries, obstetrics & gynecological surgeries, neurological surgeries), and end user (hospitals, ambulatory surgical centers, specialty clinics), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Check out more related studies published by Fact.MR Research:
Ultrasound Systems Market: Ultrasound Systems Market to grow at a whopping 7.5% CAGR, reaching US$ 17.29 Billion by 2032. The U.S. Ultrasound Systems Market tends to flourish at 7.3%.
Mycoplasma Detection Systems Market: Mycoplasma Detection Systems Market expects over 9.6% CAGR growth during 2022-2032 and projects a valuation of US$ 1.5 Billion during forecast period.
Peptide Based Cardiovascular Therapeutics Market: The global peptide-based cardiovascular therapeutics market will surpass the value of US$ 1,960 Mn by 2022 & boost the sales revenue in the forecast period.
Adult Cardiovascular Surgical Instruments Package Market: Adult Cardiovascular Surgical Instruments Package Market to grow a healthy CAGR recording an exponential revenue sales during the period of 2018-2026, Fact.MR.
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Contact Person: Anup Kumar
Address 1: US Sales Office:
Address 2: 11140 Rockville Pike
Country: United States
Release Id: 0202232377
The post Global Sales of Autotransfusion Systems Market Is Estimates To Rise at a CAGR of 4% by 2033 appeared first on King Newswire.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Stock Market. News journalist was involved in the writing and production of this article.